APRIL THORNTON: Open Payments
NPI 1952744740 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 23 payments from 14 companies in 2025. Trend: 2023 $533 · 2024 $681 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 3 | $79 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $57 |
| Edwards Lifesciences Corporation | 1 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Amgen Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: XYOSTED, NEXLETOL, Rybelsus, AIRSUPRA, CAPLYTA, OTEZLA, FREESTYLE LIBRE 3, MINIMED 780G.
Industry payments across TN — which companies pay providers there.
